Neutralizing gut-derived lipopolysaccharide as a novel therapeutic strategy for severe leptospirosis
Neutralizing gut-derived lipopolysaccharide as a novel therapeutic strategy for severe leptospirosis
About this item
Full title
Author / Creator
Xie, Xufeng , Chen, Xi , Zhang, Shilei , Liu, Jiuxi , Zhang, Wenlong and Cao, Yongguo
Publisher
England: eLife Science Publications, Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: eLife Science Publications, Ltd
Subjects
More information
Scope and Contents
Contents
Leptospirosis is an emerging infectious disease caused by pathogenic
Leptospira
spp. Humans and some mammals can develop severe forms of leptospirosis accompanied by a dysregulated inflammatory response, which often results in death. The gut microbiota has been increasingly recognized as a vital element in systemic health. However, the precis...
Alternative Titles
Full title
Neutralizing gut-derived lipopolysaccharide as a novel therapeutic strategy for severe leptospirosis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_993dbe353e44481492640daf6f0dfba6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_993dbe353e44481492640daf6f0dfba6
Other Identifiers
ISSN
2050-084X
E-ISSN
2050-084X
DOI
10.7554/eLife.96065
